Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EJ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.31.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BY.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.618NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.458NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
W.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.264.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.190NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.552NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
M.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.429NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
U.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.373NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.80NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.433NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.242NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.449NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.152NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.146NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used